29 Jun mVacciNation selected as an innovation that can “drastically improve vaccine coverage”

Posted at 13:54h in Health & Social Innovation Solutions, Thought Leadership by
Casper Strydom  | 29 June 2018

One of Mezzanine’s health products, mVacciNation, has been selected by the Gavi Vaccine Alliance as one of “11 finalist innovations which, if scaled, have the potential to drastically improve vaccine coverage and equity in developing countries — one of the greatest challenges in immunisation today”.

“Gavi is an international organisation – a global Vaccine Alliance, bringing together public and private sectors with the shared goal of creating equal access to new and underused vaccines for children living in the world’s poorest countries.”

– from the Gavi website

Mezzanine and their mVacciNation partners, GlaxoSmithKline (GSK) and Amref have been invited to attend the Gavi INFUSE 2018 workshop. The workshop, organised in partnership with Matter Group and OpenIDEO, will take place on 10-11 July 2018 at the World Economic Forum, Centre for the Fourth Industrial Revolution in San Francisco.
Click to enlarge
Print page